Prognostic impact of cytokines and chemokines in bronchoalveolar lavage fluid on acute exacerbation of fibrosing interstitial lung disease

被引:0
|
作者
Furuta, Katsuyuki [1 ]
Fujimoto, Daichi [1 ]
Matsunashi, Atsushi [2 ]
Shibaki, Ryota [1 ]
Taniya, Shinnosuke [3 ]
Tanaka, Masanori [1 ]
Shimada, Yuri [2 ]
Nagata, Kazuma [2 ]
Tomii, Keisuke [2 ]
Yamamoto, Nobuyuki [1 ]
机构
[1] Wakayama Med Univ, Internal Med 3, 811Kimiidera, Wakayama 6418509, Japan
[2] Kobe City Med Ctr Gen Hosp Kobe, Dept Resp Med, Kobe, Japan
[3] Revorf Co Ltd, Tokyo, Japan
关键词
Interstitial lung disease; Lung fibrosis; cytokine; Biomarker; Retrospective study; IDIOPATHIC PULMONARY-FIBROSIS; GM-CSF; INFLAMMATION; IL-8;
D O I
10.1016/j.rmed.2024.107721
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background and objective: Acute exacerbation of fibrosing interstitial lung disease (AE-FILD) is a serious condition with a high mortality rate. We aimed to comprehensively analyze cytokines in bronchoalveolar lavage fluid and their association with the clinical course of AE-FILD. Methods: We retrospectively enrolled 60 patients with AE-FILD who underwent bronchoalveolar lavage. We comprehensively measured 44 cytokines and chemokines in the obtained bronchoalveolar lavage fluid using a Luminex analyzer. Patients were grouped into those who died within 90 days (non-survival group) and survived beyond 90 days (survival group) to investigate the association of the levels of cytokines and chemokines with mortality. Results: The levels of matrix metalloproteinase 1 (p = 0.003), granulocyte-macrophage colony-stimulating factor (p = 0.040), interleukin 6 (p = 0.047), interleukin 8 (p = 0.050), monocyte chemoattractant protein-1 (p = 0.043), and eotaxin (p = 0.044) were significantly higher in the non-survival group than in the survival group. In the receiver operating characteristic analysis, their areas under the curve were 0.80, 0.68, 0.71, 0.70, 0.70, and 0.72, respectively. Using machine learning with these six cytokines and chemokines, the predictive accuracy for the survival group was 0.94. Conclusions: Our study demonstrated that several cytokines and chemokines in bronchoalveolar lavage fluid could be prognostic predictors in patients with AE-FILD.
引用
收藏
页数:7
相关论文
共 50 条
  • [31] ASBESTOS FIBERS IN BRONCHOALVEOLAR LAVAGE FLUID IN PATIENTS WITH DIFFUSE INTERSTITIAL LUNG-DISEASE
    BRAUDE, AC
    CHAMBERLAIN, DW
    REBUCK, AS
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1982, 125 (04): : 106 - 106
  • [32] The Prevalence and Clinical Significance of Eosinophilia in Bronchoalveolar Lavage Fluid in Patients With Interstitial Lung Disease
    Bowes, K. S.
    Callum, J.
    Yioe, V.
    Stanel, S.
    Greaves, M.
    Montero, A.
    Ortega, P. Rivera
    Hayton, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
  • [33] Chemokines are important cytokines in the pathogenesis of interstitial lung disease
    Keane, MP
    Standiford, TJ
    Strieter, RM
    EUROPEAN RESPIRATORY JOURNAL, 1997, 10 (06) : 1199 - 1202
  • [34] Prognostic Value of Bronchoalveolar Lavage in CTD-related Interstitial Lung Disease: An Observational Study
    Gysan, Maximilian
    Pochepnia, Svitlana
    Prosch, Helmut
    Lehmann, Antje
    Lee, Silvia
    Renner, Andreas
    Gompelmann, Daniela
    Idzko, Marco
    Aykara, Iris
    Anderle, Karolina
    Weber, Peter
    Kiener, Hans
    Bonelli, Michael
    Mrak, Daniel
    Aletaha, Daniel
    Lechner-Radner, Helga
    Kastrati, Kastriot
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 4150 - 4152
  • [35] The impact of bronchoalveolar lavage on the diagnosis of undifferentiated interstitial lung disease alongside a multidisciplinary discussion
    Khan, Wafa B.
    Gallagher, Harry M.
    Jayasimhan, Dilip
    Dray, Michael
    Chang, Catherina L.
    CHRONIC RESPIRATORY DISEASE, 2023, 20
  • [36] Acute exacerbation in interstitial lung disease
    Alhamad, Esam H.
    Cal, Joseph G.
    Alrajhi, Nuha N.
    AlBoukai, Ahmad A.
    ANNALS OF THORACIC MEDICINE, 2021, 16 (02) : 178 - 187
  • [37] Acute exacerbation in interstitial Lung Disease
    Leuschner, Gabriela
    Behr, Juergen
    FRONTIERS IN MEDICINE, 2017, 4
  • [38] BRONCHOALVEOLAR LAVAGE FLUID HISTAMINE LEVELS IN INTERSTITIAL LUNG-DISEASES
    CASALE, TB
    TRAPP, S
    ZEHR, B
    HUNNINGHAKE, GW
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1988, 138 (06): : 1604 - 1608
  • [39] Endotoxin markers in bronchoalveolar lavage fluid of patients with interstitial lung diseases
    Szponar, Bogumila
    Larsson, Lennart
    Domagala-Kulawik, Joanna
    MULTIDISCIPLINARY RESPIRATORY MEDICINE, 2012, 7
  • [40] Bronchoalveolar lavage and response to cyclophosphamide in scleroderma interstitial lung disease
    Strange, Charlie
    Bolster, Marcy B.
    Roth, Michael D.
    Silver, Richard M.
    Theodore, Arthur
    Goldin, Jonathan
    Clements, Philip
    Chung, Joanie
    Elashoff, Robert M.
    Suh, Robert
    Smith, Edwin A.
    Furst, Daniel E.
    Tashkin, Donald P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2008, 177 (01) : 91 - 98